You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: long-acting insulin analogues do not improve glycaemic control but reduce nocturnal hypoglycaemia

https://doi.org/10.1136/ebm.13.3.79

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Dr K Tran

    Correspondence to: Dr K Tran, Canadian Agency for Drugs and Technologies in Health, Ottawa, Ontario, Canada; pubs@cadth.ca

    QUESTION

    In patients with diabetes mellitus, what is the efficacy of long acting insulin analogues (LAIAs) compared with human insulin or oral antidiabetic agents?

    REVIEW SCOPE

    Studies selected compared LAIAs (insulin glargine or insulin detemir) with conventional human insulin (including neutral protamine Hagedorn [NPH]) or oral antidiabetic agents in patients with type 1 or 2, or gestational diabetes. Outcomes included glycaemic control (haemoglobin A1c [HbA1c] concentration) and hypoglycaemic episodes.

    REVIEW METHODS

    Medline, EMBASE/Excerpta Medica, BIOSIS Previews, PASCAL, PubMed, and Cochrane Database of Systematic Reviews (1990 to February 2006); Health Economics Evaluation Database; and websites of regulatory and health technology assessment agencies and professional associations were searched for randomised controlled …

    View Full Text

    Footnotes

    • Source of funding: Canadian federal, provincial, and territorial governments.